Le Grap à la journée psychédélique de l'AFPBN à l'ICM

Le GRAP présent le 5 juin 2025 à la journée organisée par la section médecine psychédélique de l'AFPBN. Journée "Psychedelic medicine: scientific perspective, 1st national symposium of the psychedelic medicine section of the AFBN"

Le programme : (ou télécharger ici)

8:45 AM: Welcome

9:00 AM: Introduction - Bureau of the Psychedelic Medicine Section

09:15–10:00 AM: Pharmacology of psychedelics:

similarities and differences

Matthias Liechti, Basel University

10:00–10:45 AM: Psychedelic therapies - How do they seem to differ from

existing treatments in mental health?

David Erritzoe, Imperial College of London

10:45 –11:00 AM: Coffee Break

11:00 –11:45 AM: Mechanisms of psychedelics in the treatment of

alcohol dependence

Mickael Naassila, University of Picardy

11:45–12:30 AM: Are the neurobiological properties of psychedelics

predictive of therapeutic effects in addiction?

Christian Lüscher, University of Geneva

12:30–1:30 PM: Lunch Break

1:30 –2:00 PM: Processes and challenges in setting up a psilocybin study

in France: example of the first French study (PAD)

Amandine Luquiens, CHU Nîmes

2:00–2:45 PM: Global brain effects of psychedelics and therapeutic

implications

Katrin Preller, University Hospital for Psychiatry, Zurich

2:45–3:30 PM: LSD in the treatment of mood and anxiety disorders

Frederike Holze, Basel University

3:30–3:45 PM: Coffee Break

3:45 –4:30 PM: Psilocybin as a catalyst for psychotherapy?

Insights from the German EPIsoDE Trial

Lea Mertens, Central Institute of Mental Health,

University of Heidelberg

4:30–5:15 PM: Prospects on the use of psychedelic treatments

as antidepressant therapy

Guy Goodwin, COMPASS Pathways, London

5:15–5:30 PM: Closing Remarks, Bureau of the Psychedelic Medicine Section